UBcare. Co., Ltd. (KOSDAQ:032620)
South Korea · Delayed Price · Currency is KRW 3,905.00
-25.00 (-0.64%)
At close: Apr 9, 2026
UBcare. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 197,696 | 190,597 | 154,041 | 133,343 | 111,762 |
Other Revenue | - | - | -0 | - | - |
| 197,696 | 190,597 | 154,041 | 133,343 | 111,762 | |
Revenue Growth (YoY) | 3.72% | 23.73% | 15.52% | 19.31% | 6.64% |
Cost of Revenue | 96,163 | 95,358 | 73,409 | 65,820 | 52,955 |
Gross Profit | 101,533 | 95,239 | 80,632 | 67,523 | 58,807 |
Selling, General & Admin | 84,895 | 83,850 | 71,109 | 57,632 | 46,086 |
Research & Development | 2,991 | 1,617 | 1,663 | 289.26 | - |
Amortization of Goodwill & Intangibles | 2,064 | 1,434 | 1,344 | 1,208 | 1,073 |
Other Operating Expenses | 505.5 | 518.93 | 530.29 | 282.51 | 340.34 |
Operating Expenses | 93,780 | 90,307 | 77,186 | 60,308 | 49,152 |
Operating Income | 7,753 | 4,932 | 3,446 | 7,215 | 9,654 |
Interest Expense | -1,660 | -1,471 | -720.45 | -379.79 | -255.18 |
Interest & Investment Income | 994.11 | 824.12 | 1,159 | 1,258 | 888.31 |
Earnings From Equity Investments | 35,407 | -1,046 | -3,659 | -3,449 | 1,338 |
Currency Exchange Gain (Loss) | -40.13 | 64.36 | 77.61 | -803.98 | - |
Other Non Operating Income (Expenses) | 155.22 | -2,316 | 1,384 | 189.77 | 29.96 |
EBT Excluding Unusual Items | 42,610 | 987.81 | 1,687 | 4,029 | 11,656 |
Gain (Loss) on Sale of Investments | 665.47 | 39.93 | 330.48 | 3,050 | 283.98 |
Gain (Loss) on Sale of Assets | -425.85 | 29.27 | 90.62 | 32.81 | 7,323 |
Asset Writedown | -3,862 | -0.03 | -297.87 | -219.52 | -3,421 |
Other Unusual Items | - | - | 130.38 | - | - |
Pretax Income | 38,988 | 1,057 | 1,941 | 6,892 | 15,842 |
Income Tax Expense | 1,168 | 2,623 | 1,748 | 1,985 | 3,089 |
Earnings From Continuing Operations | 37,819 | -1,566 | 193.06 | 4,908 | 12,753 |
Earnings From Discontinued Operations | - | - | -1,154 | -800.55 | 861.35 |
Net Income to Company | 37,819 | -1,566 | -961.23 | 4,107 | 13,614 |
Minority Interest in Earnings | -842.71 | -20.53 | -750.45 | -521.25 | -302.96 |
Net Income | 36,977 | -1,586 | -1,712 | 3,586 | 13,312 |
Net Income to Common | 36,977 | -1,586 | -1,712 | 3,586 | 13,312 |
Net Income Growth | - | - | - | -73.06% | 113.52% |
Shares Outstanding (Basic) | 51 | 51 | 51 | 51 | 51 |
Shares Outstanding (Diluted) | 51 | 51 | 51 | 51 | 51 |
Shares Change (YoY) | -0.87% | 0.84% | - | - | - |
EPS (Basic) | 729.00 | -31.00 | -33.73 | 70.67 | 262.33 |
EPS (Diluted) | 729.00 | -31.00 | -33.73 | 70.67 | 262.33 |
EPS Growth | - | - | - | -73.06% | 113.52% |
Free Cash Flow | 6,522 | -1,518 | 1,155 | 2,695 | 7,529 |
Free Cash Flow Per Share | 128.58 | -29.66 | 22.77 | 53.12 | 148.38 |
Dividend Per Share | - | - | 60.000 | 60.000 | 40.000 |
Dividend Growth | - | - | - | 50.00% | -20.00% |
Gross Margin | 51.36% | 49.97% | 52.34% | 50.64% | 52.62% |
Operating Margin | 3.92% | 2.59% | 2.24% | 5.41% | 8.64% |
Profit Margin | 18.70% | -0.83% | -1.11% | 2.69% | 11.91% |
Free Cash Flow Margin | 3.30% | -0.80% | 0.75% | 2.02% | 6.74% |
EBITDA | 16,233 | 12,472 | 8,831 | 11,044 | 12,904 |
EBITDA Margin | 8.21% | 6.54% | 5.73% | 8.28% | 11.55% |
D&A For EBITDA | 8,480 | 7,540 | 5,385 | 3,830 | 3,250 |
EBIT | 7,753 | 4,932 | 3,446 | 7,215 | 9,654 |
EBIT Margin | 3.92% | 2.59% | 2.24% | 5.41% | 8.64% |
Effective Tax Rate | 3.00% | 248.12% | 90.05% | 28.79% | 19.50% |
Advertising Expenses | 1,478 | 2,318 | 1,975 | 1,443 | 1,844 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.